This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidemiology

Authoring team

The prevalence of fibromyalgia might be as high as 2-7% in developed countries (1).

  • several epidemiological studies have calculated that chronic widespread pain to be present in about 10% of the population
    • not all of these people have fibromyalgia and when consensus classification criteria for fibromyalgia published by the American College of Rheumatology (ACR) in 1990 is used the population prevalence was around 2% (2)
  • a study done using a questionnaire prepared according to the new American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia (ACR 2010) the prevalence of fibromyalgia in Germany was 2.1% and 6.4% in Minnesota, USA (2)

The disease is more common in females:

  • in the Minnesota population survey, 7.7% of women and 4.9% of men fulfilled ACR 2010 criteria for fibromyalgia
    • but only 27% of these people had been diagnosed with the condition making the prevalence of medically diagnosed fibromyalgia 2% in women but only 0.15% in men (2)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.